SCHEMBL8375555

SCHEMBL8375555

Cc1ccc(-c2cc(OCCN(C=O)OC(C)(C)C)no2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.35
RAB9A P51151 8/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HPGD P15428 2/20 0.33
TP53 P04637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
CXCR1 P25024 2/20 0.33
S1PR1 P21453 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8378889 0.90 CXCR1 (0.32) CYP1A2CYP19A1CYP2C9CYP2C19CXCR1
SCHEMBL8379540 0.90 ALDH1A1 (0.38) NPC1RAB9ACYP1A2CYP19A1CYP2C9
SCHEMBL8376906 0.90 CXCR1 (0.40) NPC1RAB9ACYP1A2CYP19A1CYP2C9
SCHEMBL8375770 0.90 CXCR1 (0.43) NPC1RAB9ASMN1; SMN2HPGDCXCR1
SCHEMBL8375559 0.90 CXCR1 (0.41) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL8378946 0.90 CXCR1 (0.40) ALDH1A1CXCR1
SCHEMBL8375816 0.89 EPHX2 (0.38) CYP1A2CYP19A1CYP2C9CYP2C19CXCR1
SCHEMBL8380142 0.89 HPGD (0.42) NPC1RAB9ACYP1A2CYP19A1CYP2C9
SCHEMBL8374994 0.88 THRB (0.38) CYP1A2CYP19A1CYP2C9CYP2C19LMNA
SCHEMBL8378839 0.86 CXCR1 (0.45) NPC1RAB9ALMNAALDH1A1CXCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed